News
Insights from Ron
2022 Cancer Highlights
January 25, 2023
The year 2022 marked another major step in the quest to towards making cancer history. Below are several highlights among ...
Read More →
Targeting T cell Checkpoints and Myeloid Suppressors is an Effective Immunotherapy in Pancreas Cancer
December 30, 2022
Pat Gulhati1and Ronald DePinho2 1Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. 1Department ...
Read More →
Opportunity in the Biomedical Roller Coaster
June 12, 2022
Even in this market meltdown, seasoned biotech innovators with decades of experience know that strong novel science in the hands ...
Read More →
The Battle for Foundational Research Funding
May 29, 2022
Twentieth-century health activist Mary Lasker, who devoted her life to securing greater research funding for cancer, is quoted as saying: ...
Read More →
Synthetic Essentiality of Tryptophan 2,3-dioxygenase 2 in APC-Mutated Colorectal Cancer
May 10, 2022
Inactivation of the adenomatous polyposis coli (APC) is common across many cancer types and serves as a critical initiating event ...
Read More →
Synthetic Essentiality of Tryptophan 2,3-dioxygenase 2 in APC-Mutated Colorectal Cancer
May 10, 2022
Inactivation of the adenomatous polyposis coli (APC) is common across many cancer types and serves as a critical initiating event ...
Read More →